HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chiara Castelli Selected Research

sarcoma glycoprotein gp96 rejection antigens

5/2005Natural killer and NK-Like T-cell activation in colorectal carcinoma patients treated with autologous tumor-derived heat shock protein 96.
10/2003Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma- and colon carcinoma-specific T cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chiara Castelli Research Topics

Disease

56Neoplasms (Cancer)
11/2022 - 03/2002
28Melanoma (Melanoma, Malignant)
01/2021 - 01/2002
7Colorectal Neoplasms (Colorectal Cancer)
11/2008 - 04/2003
4Sarcoma (Soft Tissue Sarcoma)
01/2019 - 01/2015
3Disease Progression
01/2019 - 02/2015
3Dermatofibrosarcoma
01/2017 - 01/2016
2Colonic Neoplasms (Colon Cancer)
01/2022 - 04/2003
2Neuroblastoma
10/2018 - 10/2003
2Neoplasm Metastasis (Metastasis)
01/2018 - 05/2005
1Myocardial Infarction
01/2022
1Microsatellite Instability
01/2022
1Inflammation (Inflammations)
01/2021
1Renal Cell Carcinoma (Grawitz Tumor)
01/2021
1Multiple Sclerosis
01/2021
1Lung Neoplasms (Lung Cancer)
01/2019
1Carcinogenesis
01/2019
1Hypertension (High Blood Pressure)
01/2019
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2019
1Extraskeletal Myxoid Chondrosarcoma
01/2019
1Fibrosis (Cirrhosis)
01/2019
1Hepatocellular Carcinoma (Hepatoma)
01/2018
1Experimental Melanoma
01/2018
1Mesothelioma
01/2018
1Tics (Tic)
10/2016
1Residual Neoplasm
02/2015
1Clear Cell Sarcoma
02/2015
1Virus Diseases (Viral Diseases)
10/2014
1Alveolar Soft Part Sarcoma
09/2013
1Human Influenza (Influenza)
04/2006

Drug/Important Bio-Agent (IBA)

21AntigensIBA
02/2015 - 01/2002
14Peptides (Polypeptides)IBA
10/2018 - 01/2002
9VaccinesIBA
10/2018 - 03/2002
8MART-1 AntigenIBA
02/2015 - 01/2002
6Biomarkers (Surrogate Marker)IBA
07/2021 - 03/2002
6Proteins (Proteins, Gene)FDA Link
01/2021 - 08/2003
6CytokinesIBA
04/2015 - 06/2002
6EpitopesIBA
11/2008 - 01/2002
5Pharmaceutical PreparationsIBA
01/2019 - 11/2003
5Neoplasm Antigens (Tumor Antigens)IBA
10/2018 - 06/2002
4MicroRNAs (MicroRNA)IBA
01/2021 - 12/2016
4Biological ProductsIBA
01/2021 - 03/2004
4HLA-A*02:01 antigenIBA
05/2013 - 04/2003
4Cancer VaccinesIBA
12/2012 - 04/2006
4Heat-Shock Proteins (Heat-Shock Protein)IBA
11/2008 - 03/2004
3Immune Checkpoint InhibitorsIBA
01/2021 - 01/2019
3HLA-A2 Antigen (HLA A2 Antigen)IBA
10/2018 - 01/2002
3Differentiation AntigensIBA
02/2015 - 10/2002
3Interleukin-2 (IL2)IBA
05/2013 - 04/2003
3HLA Antigens (Human Leukocyte Antigens)IBA
12/2012 - 10/2002
3Recombinant ProteinsIBA
03/2008 - 10/2003
3LigandsIBA
12/2007 - 04/2003
3Melanoma-Specific AntigensIBA
03/2007 - 06/2002
2Imatinib Mesylate (Gleevec)FDA Link
01/2017 - 02/2016
2Interleukin-6 (Interleukin 6)IBA
10/2016 - 07/2014
2Interferon-alpha (Interferon Alfa)IBA
06/2007 - 03/2007
2Epithelial Cell Adhesion MoleculeIBA
06/2007 - 10/2003
2SurvivinIBA
04/2006 - 08/2003
2sarcoma glycoprotein gp96 rejection antigensIBA
05/2005 - 10/2003
1omega-Chloroacetophenone (Mace)IBA
01/2022
1HLA-A Antigens (HLA-A)IBA
01/2022
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2021
1AnthracyclinesIBA
01/2019
1pazopanibFDA Link
01/2019
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2019
1Alanine Transaminase (SGPT)IBA
01/2019
1Leukocyte L1 Antigen Complex (Calgranulin)IBA
01/2019
1AerosolsIBA
01/2018
1Antigen-Antibody Complex (Immune Complex)IBA
01/2018
1Anti-Bacterial Agents (Antibiotics)IBA
01/2018
1NeomycinFDA LinkGeneric
01/2018
1AcidsIBA
01/2018
1VancomycinFDA LinkGeneric
01/2018
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
12/2016
1Interleukin-8 (Interleukin 8)IBA
10/2016
1Interleukin-10 (Interleukin 10)IBA
10/2016
1ChemokinesIBA
10/2016
1antineoplaston A10 (A 10)IBA
01/2016
1Sunitinib (Sutent)FDA Link
02/2015
1TrabectedinIBA
01/2015
1Phosphotransferases (Kinase)IBA
01/2015
1Monoclonal AntibodiesIBA
12/2014
1Toll-Like Receptors (Toll-Like Receptor)IBA
07/2014
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2013
1Transcription Factors (Transcription Factor)IBA
07/2010
1Bovine Serum AlbuminIBA
07/2010
112- (4'- azido- 2'- nitrophenoxy)dodecanoyl- coenzyme AIBA
11/2008
1Glucose (Dextrose)FDA LinkGeneric
11/2008
1Tyrosine (L-Tyrosine)FDA Link
05/2008
1Cadherins (E-Cadherin)IBA
05/2008
1beta CateninIBA
05/2008
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
06/2007
1Transforming Growth Factor beta (TGF-beta)IBA
06/2007
1Chemokine ReceptorsIBA
11/2005
1Fluorescein-5-isothiocyanate (FITC)IBA
05/2005

Therapy/Procedure

16Immunotherapy
07/2021 - 06/2002
11Therapeutics
11/2022 - 10/2003
2Immunomodulation
01/2021 - 01/2017
2Drug Therapy (Chemotherapy)
01/2019 - 01/2018
1Intradermal Injections
07/2010
1Biological Therapy
04/2005